The Global Landscape of Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma Incidence and Mortality in 2020 and Projections to 2040: New Estimates From GLOBOCAN 2020

入射(几何) 食管癌 医学 人口学 死亡率 癌症 腺癌 内科学 光学 物理 社会学
作者
Eileen Morgan,Isabelle Soerjomataram,Harriet Rumgay,Helen G. Coleman,Aaron P. Thrift,Jérôme Vignat,Mathieu Laversanne,Jacques Ferlay,Melina Arnold
出处
期刊:Gastroenterology [Elsevier]
卷期号:163 (3): 649-658.e2 被引量:427
标识
DOI:10.1053/j.gastro.2022.05.054
摘要

Background & AimsThe aim of this study was to provide an overview of the burden of esophageal cancer in 185 countries in 2020 and projections for the year 2040.MethodsEstimates of esophageal cancer cases and deaths were extracted from the GLOBOCAN database for 2020. Age-standardized incidence and mortality rates were calculated overall, by sex, histologic subtype (adenocarcinoma [AC] and squamous cell carcinoma [SCC]), country, and level of human development for 185 countries. The predicted burden of incidence and mortality in 2040 was calculated based on global demographic projections.ResultsGlobally, there were an estimated 604,100 new cases of, and 544,100 deaths from, esophageal cancer in 2020, corresponding to age-standardized incidence and mortality rates of 6.3 and 5.6 per 100,000, respectively. Most cases were SCCs (85% [512,500 cases]) and 14% (85,700 cases) were ACs. Incidence and mortality rates were 2- to 3-fold higher in male (9.3 and 8.2, respectively) compared with female (3.6 and 3.2, respectively) individuals. Global variations in incidence and mortality were observed across countries and world regions; the highest rates occurred in Eastern Asia and Southern and Eastern Africa and the lowest occurred in Western Africa and Central America regions. If rates remain stable, 957,000 new cases (141,300 AC cases and 806,000 SCC cases) and 880,000 deaths from esophageal cancer are expected in 2040.ConclusionsThese updated estimates of the global burden of esophageal cancer represent an important baseline for setting priorities in policy making and developing and accelerating cancer control initiatives to reduce the current and projected burden. Although primary prevention remains key, screening and early detection represent important components of esophageal cancer control in high-risk populations. The aim of this study was to provide an overview of the burden of esophageal cancer in 185 countries in 2020 and projections for the year 2040. Estimates of esophageal cancer cases and deaths were extracted from the GLOBOCAN database for 2020. Age-standardized incidence and mortality rates were calculated overall, by sex, histologic subtype (adenocarcinoma [AC] and squamous cell carcinoma [SCC]), country, and level of human development for 185 countries. The predicted burden of incidence and mortality in 2040 was calculated based on global demographic projections. Globally, there were an estimated 604,100 new cases of, and 544,100 deaths from, esophageal cancer in 2020, corresponding to age-standardized incidence and mortality rates of 6.3 and 5.6 per 100,000, respectively. Most cases were SCCs (85% [512,500 cases]) and 14% (85,700 cases) were ACs. Incidence and mortality rates were 2- to 3-fold higher in male (9.3 and 8.2, respectively) compared with female (3.6 and 3.2, respectively) individuals. Global variations in incidence and mortality were observed across countries and world regions; the highest rates occurred in Eastern Asia and Southern and Eastern Africa and the lowest occurred in Western Africa and Central America regions. If rates remain stable, 957,000 new cases (141,300 AC cases and 806,000 SCC cases) and 880,000 deaths from esophageal cancer are expected in 2040. These updated estimates of the global burden of esophageal cancer represent an important baseline for setting priorities in policy making and developing and accelerating cancer control initiatives to reduce the current and projected burden. Although primary prevention remains key, screening and early detection represent important components of esophageal cancer control in high-risk populations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
糟糕的师关注了科研通微信公众号
刚刚
刚刚
Gakay完成签到,获得积分10
1秒前
。。完成签到 ,获得积分10
1秒前
热心市民小红花完成签到,获得积分0
2秒前
Sukey完成签到,获得积分10
2秒前
CipherSage应助自然的致远采纳,获得10
2秒前
闻闻完成签到 ,获得积分10
2秒前
2秒前
3秒前
漫柯完成签到 ,获得积分10
3秒前
王宗陵关注了科研通微信公众号
3秒前
thanks完成签到,获得积分10
4秒前
4秒前
无限续完成签到,获得积分10
4秒前
酸奶冻完成签到,获得积分10
5秒前
5秒前
5秒前
研友_8QxN1Z完成签到,获得积分10
5秒前
养乐多发布了新的文献求助10
6秒前
中午饭完成签到,获得积分10
6秒前
云中诗完成签到,获得积分10
6秒前
哈哈发布了新的文献求助10
7秒前
9秒前
9秒前
个性松发布了新的文献求助10
9秒前
信封发布了新的文献求助10
9秒前
彭于晏发布了新的文献求助10
9秒前
爆米花应助生动秋白采纳,获得10
9秒前
李hk完成签到,获得积分10
10秒前
kanglan发布了新的文献求助30
10秒前
11秒前
12秒前
默默完成签到,获得积分10
12秒前
12秒前
GakkiSmile完成签到,获得积分10
13秒前
俭朴的天薇完成签到,获得积分10
13秒前
13秒前
筱唐完成签到,获得积分10
14秒前
An完成签到,获得积分10
14秒前
高分求助中
The ACS Guide to Scholarly Communication 2500
Sustainability in Tides Chemistry 2000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
Pharmacogenomics: Applications to Patient Care, Third Edition 800
A Dissection Guide & Atlas to the Rabbit 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3081852
求助须知:如何正确求助?哪些是违规求助? 2734912
关于积分的说明 7534916
捐赠科研通 2384515
什么是DOI,文献DOI怎么找? 1264364
科研通“疑难数据库(出版商)”最低求助积分说明 612614
版权声明 597600